John Friend
Chief Executive Officer bij KAZIA THERAPEUTICS LIMITED
Profiel
John E.
Friend is currently the Chief Executive Officer at Kazia Therapeutics Ltd.
Prior to his current position, he served as the Senior Vice President-Medical & Scientific Affairs at Helsinn Therapeutics (U.S.), Inc. from 2010 to 2017.
He then worked as the Chief Medical Officer & Vice President at Cellectar Biosciences, Inc. from 2017 to 2018, and again from 2020 to 2021.
Additionally, he held the position of Chief Medical Officer at Druggability Technologies Holdings Ltd.
(New Jersey).
Dr. Friend obtained his undergraduate degree from Southern Methodist University and his doctorate from Robert Wood Johnson Medical School.
Actieve functies van John Friend
| Bedrijven | Functie | Begin |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Chief Executive Officer | 01-05-2023 |
Eerdere bekende functies van John Friend
| Bedrijven | Functie | Einde |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 02-11-2021 |
| CELLECTAR BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 27-11-2018 |
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Chief Tech/Sci/R&D Officer | 01-04-2017 |
| Druggability Technologies Holdings Ltd. (New Jersey) | Chief Tech/Sci/R&D Officer | - |
Opleiding van John Friend
| Southern Methodist University | Undergraduate Degree |
| Robert Wood Johnson Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KAZIA THERAPEUTICS LIMITED | Health Technology |
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Health Technology |
| Druggability Technologies Holdings Ltd. (New Jersey) |
